Methadone

Pediatric
  • TRADE NAMES: Dolophine (Roxane); Eptadone; L-Polamidon; Mephenon; Metadon; Methadose (Mallinckrodt)
  • INDICATIONS: Pain, narcotic addiction
  • CLASS: Opiate agonist
  • HALF-LIFE: 15–25 hours

Methadone is not licensed for use in children though it can be employed for the management of neonatal opiate withdrawal syndrome

Our database has 51 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top